Case Reports

Misleading Diagnosis of Idiopathic Pulmonary Fibrosis: A Clinical Concern

Author and Disclosure Information

 

References

Diagnosing IPF cannot be solely based on a lung biopsy consistent with UIP. Appropriate diagnosis should consider the clinical presentation; PFT, laboratory findings (including rheumatologic workup), imaging (especially radiographic patterns), and biopsies. Moreover, the pathologic characteristic of IPF, which is UIP, can be found with other diseases, such as SS. Thus, it is important to make an accurate diagnosis to provide the appropriate treatment available. Patients with ILD associated with SS who have worsening symptoms, PFT, and radiographic abnormalities may be treated with oral prednisone (daily dose: 1 mg/kg).

[embed:render:related:node:103978]

Conclusion

This case highlights the importance of making an adequate diagnosis of ILD considering that available treatments differ for all possible etiologies other than IPF. This is a true clinical concern taking into account that many patients might be receiving inappropriate therapy for IPF diagnosis, as illustrated in the case study.

Pages

Recommended Reading

An Action Plan for Better COPD Care
Federal Practitioner
Smoking and Food Insecurity: How to Solve a Dual Challenge?
Federal Practitioner
VA Partnership Expands Access to Lung Screening Programs
Federal Practitioner
Duodenal Perforation After Endoscopic Procedure
Federal Practitioner
Shorter Length of Stay May Be Better for Some PE Patients
Federal Practitioner
Innovative Therapies for Severe Asthma
Federal Practitioner
Who’s Smoking What?
Federal Practitioner
Maternal Weight Impacts Childhood Asthma
Federal Practitioner
Pulmonary Mucormycosis in a Patient With Uncontrolled Diabetes
Federal Practitioner
Risk Factors Associated With Multidrug-Resistant Pneumonia in Nonhospitalized Patients
Federal Practitioner

Related Articles